INCA - Brazilian National Cancer Institute

Rio de Janeiro 20220-280

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling